Kate Misso
- Pharmacology top 0.5%
- Toxicology top 1%
- Health top 2%
-
- Pain Management and Opioid Use 4
-
- Pain Mechanisms and Treatments 5
-
- Spondyloarthritis Studies and Treatments 4
- Rheumatoid Arthritis Research and Therapies 4
-
- Psoriasis: Treatment and Pathogenesis 4
-
- Fibromyalgia and Chronic Fatigue Syndrome Research 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Jos KleijnenPenny WhitingShona LangSteve RyderRobert WolffAdrían V. HernándezSteven DuffyMarcello Di Nisio
- Journals
- Health Technology Assessment (10 papers)PharmacoEconomics (4 papers)Current Medical Research and Opinion (3 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Kate Misso
52 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Pharmacology 1.5k
- Toxicology 171
- Critical Care and Intensive Care Medicine 187
- Health 252
- Anesthesiology and Pain Medicine 157
Countries citing papers authored by Kate Misso
This map shows the geographic impact of Kate Misso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Misso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Misso more than expected).
Fields of papers citing papers by Kate Misso
This network shows the impact of papers produced by Kate Misso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Misso. The network helps show where Kate Misso may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kate Misso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 27 | |
| 2 | 2021 | 38 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 14 | |
| 5 | 2020 | 8 | |
| 6 | 2018 | 3 | |
| 7 | 2017 | 64 | |
| 8 | 2016 | 8 | |
| 9 | Cannabinoids for Medical Usebreakdown → | 2015 | 1492 |
| 10 | 2014 | 66 | |
| 11 | 2013 | 178 | |
| 12 | 2011 | 67 | |
| 13 | 2011 | 22 | |
| 14 | 2009 | 63 | |
| 15 | 2008 | 281 | |
| 16 | 2006 | 200 | |
| 17 | 2006 | 90 | |
| 18 | Re: Hutton J, Brown R. Use of economic evaluation in decision-making: what needs to change? (Editorial) Value Health 2002;5:65-6. | 2002 | 101 |
| 19 | 2001 | 19 | |
| 20 | Fluoridation of Drinking Water: a systematic review of its efficacy and safety | 2000 | 4 |
About Kate Misso
Kate Misso is a scholar working on Anesthesiology and Pain Medicine, Rheumatology and Family Practice, having authored 52 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (5 papers), Pain Management and Opioid Use (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Pharmacology (1.5k citations), Toxicology (171 citations) and Critical Care and Intensive Care Medicine (187 citations). Kate Misso has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Jos Kleijnen, Penny Whiting, Shona Lang, Steve Ryder, Robert Wolff, Adrían V. Hernández, Steven Duffy, Marcello Di Nisio, Sohan Deshpande and J. Christiaan Keurentjes. Their work appears in journals such as Health Technology Assessment, PharmacoEconomics, Current Medical Research and Opinion, Value in Health and Journal of Health Services Research & Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.